200mg Fabiflu Favipiravir Tablets

₹ 210/Strip

Strength200 mg
Packing TypeBox
BrandFabiflu
Packaging Size1x34 Tablets
ManufacturerGlenmark Pharmaceutical
TreatmentPrescribed to COVID-19 patients with mild to moderate symptoms
Country of originMade in India
AvailabilityIn Stock
View in Hindi 200 मिग्रा फैबिफ्लू फैविपिरावीर टैबलेट
FabiFlu Favipiravir Tablet: Overview. FabiFlu Favipiravir Tablet is an antiviral medication approved by the Indian government to treat COVID-19 patients with mild to moderate symptoms. It is a generic version of the drug Avigan, developed by a Japanese company, and is manufactured in India by Glenmark Pharmaceuticals.

Exports To: United States Of America | United Kingdom | Australia | Canada | Korea

Find products similar to 200mg Fabiflu Favipiravir Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNagpur
ShippingAs per delivery location

Product Image

200mg Fabiflu Favipiravir Tablets-1200mg Fabiflu Favipiravir Tablets-2

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
29-05-2023
Legal Status of Firm
Partnership
Nature of Business
Service Provider and Others
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Sept 2019
GST
27AEZFS0348L1Z7
Import Export Code (IEC)
AEZFS*****
Exports to
United States Of America | United Kingdom | Australia | Canada | Korea
Established in the year of 2019, we “Sky Line Impex.” are Wholesaler and Exporter of an Pharmaceutical Injection, Pharmaceutical Tablets, Anti Cancer Medicines, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
 
For our accomplishment story, we are grateful to our Mis. Kirti Kalyani, whose continual backing and direction have been useful to us for attaining exponential development in the current market.